Yakov Kogan

Yakov Kogan joined Panacela Labs, Inc from the date of its foundation. He holds a Ph.D. degree in Molecular Biology, as well as an M.S. degree in Biology from Moscow State University and an MBA from the University of Chicago. Also Yakov Kogan is Chief Executive Officer of Cleveland BioLabs, Inc. (NASDAQ: CBLI) which is an innovative biopharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. Yakov Kogan worked at the University of Chicago, where he led the execution of several sophisticated genome sequencing projects.